Skip to main content
. 2022 Aug 25;11(9):1645. doi: 10.3390/antiox11091645

Figure 4.

Figure 4

Effect of treatment with sorafenib (A) and crocin (B) on HepG2 cell viability. IC50 value corresponds to the concentration leading to a loss of 50% of cell viability. Data were expressed as mean ± SEM for three replicates (n = 3).